Neri, Christian
Christian Neri researcher
VIAF ID: 219437058 (Personal)
Permalink: http://viaf.org/viaf/219437058
Preferred Forms
- 100 0 _ ‡a Christian Neri ‡c researcher
-
- 100 1 _ ‡a Neri, Christian
- 100 1 _ ‡a Neri, Christian
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease. | |
Anticipation in schizophrenia: no evidence of expanded CAG/CTG repeat sequences in French families and sporadic cases | |
Association between Cognitive Status before Surgery and Outcomes in Elderly Patients with Hip Fracture in a Dedicated Orthogeriatric Care Pathway | |
Balancing protein similarity and gene co-expression reveals new links between genetic conservation and developmental diversity in invertebrates | |
Biomarkers of vascular dysfunction and cognitive decline in patients with Alzheimer's disease: no evidence for association in elderly subjects. | |
C. elegans as a model for human inherited degenerative diseases | |
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. | |
Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures | |
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues | |
Combining feature selection and shape analysis uncovers precise rules for miRNA regulation in Huntington's disease mice | |
Common disease signatures from gene expression analysis in Huntington's disease human blood and brain | |
Contribution à l'étude des effets antitumoraux directs des analogues de la GnRH sur le tissu mammaire : caractérisation des effets antiprolifératifs directs du D-Trp#6GnRH in vitro et in vivo, recherche d'anticorps contre le récepteur de la GnRH | |
[A contribution of the C. elegans model to the role of glial cells to the neuronal response] | |
Contribution to study the role of molecular partners of Huntington in the physiopathology of huntington disease : identification and caracterisation of proteins CA150 and CIP4. | |
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase | |
Detection and characterization of targets and biomarkers for Huntington's disease using a combined approach based on Caenorhabditis elegans. | |
Détection et caractérisation de cibles et de marqueurs pour la maladie de Huntington par une approche combinée basée sur le nématode Caenorhabditis elegans | |
Développement, longévité et toxicité cellulaire : utilisation du modèle Caenorhabditis elegans pour étudier des gènes modificateurs d'une pathologie dégénérative : étude du réseau génétique FoxO/DAF-16 dans la dystrophie musculaire oculopharyngée | |
Dietary restriction: standing up for sirtuins | |
Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells | |
Etude du rôle de la protéine kinase DCLK3 dans les mécanismes de neurodégénérescence dans la maladie de Huntington | |
FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16INK4a increase | |
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis | |
GnRH complementary peptide antibodies: outcome in GnRH receptor immunoanalysis | |
Huntingtin-interacting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity. | |
Huntington's disease, gene network, transcriptomics analysis, computational biology, spectral graph theory, neurodegenerative mechanisms. | |
Implication of longevity and energy metabolism modulators in mutant PABPN1 cytotoxicity : therapeutic strategies for muscle protection in oculopharyngeal muscular dystrphy. | |
Insulin signaling in the aging of healthy and proteotoxically stressed mechanosensory neurons | |
Integration of β-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin toxicity | |
Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons. | |
Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway. | |
Loss of glutathione redox homeostasis impairs proteostasis by inhibiting autophagy-dependent protein degradation | |
Meet the editorial board | |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | |
Modélisation et prédiction de la dynamique moléculaire de la maladie de Huntington par la théorie des graphes au travers des modèles et des espèces, et priorisation de cibles thérapeutiques | |
Morphological remodeling of C. elegans neurons during aging is modified by compromised protein homeostasis. | |
Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. | |
Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice | |
New light on polyglutamine neurodegenerative disorders: interference with transcription | |
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia | |
The Oxygen Paradox, the French Paradox, and age-related diseases. | |
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease | |
Polyglutamine tracts in schizophrenia: gaining new insights | |
Preface | |
Réseaux de gènes, évolution / développement et pathologie : définition et applications d'un nouveau concept d'analyse de la conservation génétique et fonctionnelle | |
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. | |
Retrospective Evaluation of a Restrictive Transfusion Strategy in Older Adults with Hip Fracture | |
Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology. | |
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement | |
Role and Therapeutic Potential of the Pro-Longevity Factor FOXO and Its Regulators in Neurodegenerative Disease. | |
Rôles physiopathologiques des anomalies de la régulation de la transcription dans la maladie de Huntington : étude des effets neuroprotecteurs de CA150 et de SIR-2 | |
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis | |
The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's disease | |
Study of the role of a new striatal marker in the neurodegenerescence of Huntington's disease. | |
The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity | |
মুখবন্ধ | |
সম্পাদকীয় |